Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)

Clinical trial NCT01963611 · TERMINATED

Trial details

NCT number: NCT01963611
Sponsor: EMD Serono
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2013-10-01
Primary completion: 2015-03-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.